Glucagon-like peptide-1 receptor agonists and the risk of atrial fibrillation in adults with diabetes: a real-world study
Yunwen Xu, Thomas A. Boyle, Beini Lyu, Shoshana H. Ballew, Elizabeth Selvin, Alex R. Chang, Lesley A. Inker, Morgan E. Grams, Jung‐Im Shin
Topics & Concepts
MedicineAtrial fibrillationDiabetes mellitusGlucagon-like peptide-1Internal medicineEndocrinologyCardiologyType 2 diabetesDiabetes Treatment and ManagementBariatric Surgery and OutcomesAtrial Fibrillation Management and Outcomes